C
Covalon Technologies Ltd. COV.V
TSX
Recommendation
Prev Close
$1.73
Volume
--
Avg Vol (90D)
20,240
Market Cap
$34.58M
Dividend & Yield
--
52-Week Range
$1.68 - $3.65
P/E (TTM)
35.74
EPS (TTM)
$0.05
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$23.48M
EBITDA (TTM)
$1.53M
EBIT (TTM)
$1.26M
Net Income (TTM)
$1.47M
Balance Sheet
Total Assets (Q)
$25.93M
Total Debt (Q)
$1.62M
Total Liabilities (Q)
$3.87M
Book Value Per Share (Q)
$0.8046
Cash Flow
Cash from Operations (TTM)
$1.63M
Cash from Investing (TTM)
-$610.20K
Cash from Financing (TTM)
-$380.10K
Net Change in Cash (TTM)
$426.00K
Filings
Filing Date
Thursday, December 11, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 16 and 20 (est)
Price History
Loading...
Beta
0.61
7-Day Total Return
6.78%
30-Day Total Return
0.00%
60-Day Total Return
-11.17%
90-Day Total Return
-36.83%
Year to Date Total Return
-42.45%
1-Year Total Return
-45.59%
2-Year Total Return
76.95%
3-Year Total Return
-17.94%
5-Year Total Return
73.66%
52-week Low
Dec 19, 2025 - $1.68
52-week High
Jan 06, 2025 - $3.65
Valuation
Market Cap
$34.58M - Nano Cap
Enterprise Value
$23.56M
Price/Sales (TTM)
2.04
Price/Book (Q)
2.15
Dividends and Shares
Shares Outstanding
27.73
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
covalon.com
Phone Number
905-568-8400
Address
1660 Tech Avenue
Mississauga, ON L4W 5S7
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the... more